In 2020, the company’s loss widened to 691 million yuan from 553 million yuan the previous year. But the year-on-year growth rate slowed to around 40% in the first quarter of this year, with revenue reaching 223 million for the period, the prospectus shows. Its revenue nearly doubled in 2020 to 942 million yuan ($147 million) from nearly 500 million yuan the previous year. It earns money through a number of channels, including sales of medicines, infusion and injection services, and from fees generated by service contracts with life science companies and medical associations. LinkDoc began operations in 2014, and said it has cumulatively cared for 3.5 million patients since 2015. The company calls itself the “largest oncology patient-centric continuous care platform in China,” with a growing network of 34 patient centers nationwide at the end of March. The emerging national health plan still provides very basic coverage, leaving lots of room for providers of value-added services like those offered by LinkDoc. But it is still going through a massive transformation from a previous system of basic cradle-to-grave care provided by state-owned employers, to a more European-style system where most people receive such care through a national network of publicly owned hospitals and clinics that accept payments from a national health plan.
#SOURCES KEEP XIMALAYA LINKDOC IPOTIMES OFFLINE#
“The (LinkDoc) platform integrates online and offline channels to help patients, especially those who suffer from cancer, better manage their illnesses as a chronic condition in and out of hospital,” the company said in the filing.Ĭhina is the world’s second-largest health care market, growing in step with the country’s rapid economic growth. Such figures are frequently referred to as “placeholders,” and are usually raised or lowered based on how well investors receive the offering. LinkDoc, whose backers include e-commerce giant Alibaba’s separately listed Alibaba Health Information Technology Ltd., set a preliminary fundraising target of about $100 million for the listing, according to its prospectus filed with the U.S. has filed for a New York IPO, becoming the latest in a new generation of Chinese companies trying to tap demand for higher quality health care services to supplement the basic care received under the country’s national health plan. Money-losing medical services provider LinkDoc Technology Ltd.
0 kommentar(er)
